# SSR 16-4p: SSR 16-4p: Titles II and XVI: Using Genetic Test Results to Evaluate Disability

> Federal · Rulings · In force

URL: https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_16_4p

## Section

- **Citation:** SSR 16-4p
- **Heading:** SSR 16-4p: Titles II and XVI: Using Genetic Test Results to Evaluate Disability
- **Jurisdiction:** Federal
- **Kind:** Rulings
- **Status:** In force
- **Text as of:** August 14, 2026
- **Source:** Compiled text
- **Location:** Social Security Rulings / DI / Disability Insurance — Medical / SSR 16-4p

## Text

Effective Date: April 13, 2016 Federal Register
Vol. 81, No. 71, page 21944 Corrected by Federal
Register Vol. 81, No. 77, page 23543

Policy Interpretation Ruling

PURPOSE: This SSR explains how we consider medical
evidence containing the results of genetic tests and helps adjudicators,
including disability examiners and medical and psychological
consultants, consistently apply our policies in disability
claims. [1]

CITATIONS: Sections 216(i) , 223(d) , 223(f) , 1614(a)(3) and 1614(a)(4) of the Social Security Act, as amended; 20 CFR Part 401; 20 CFR 401.55 , 404.1505 , 404.1508 , 404.1512 , 404.1513 , 404.1519a , 404.1519m , 404.1520 , 404.1520b , 404.1527 , 404.1528 , 404.1529 , 404.1545 , 416.905 , 416.906 , 416.908 , 416.911 , 416.912 , 416.913 , 416.919a , 416.919m , 416.920 , 416.920b , 416.924 , 416.924a , 416.926a , 416.927 , 416.928 , 416.929 ,
and 416.945 ;
and 20 CFR
Part 404, appendix 1 .

INTRODUCTION: In all claims for disability, we need objective medical
evidence to establish the existence of a medically determinable
impairment (MDI). Genetic test results sometimes are a part of this
objective medical evidence and can also be of value at other points in
the sequential evaluation process. In this ruling, we provide basic
information about genetic testing and clarify how we apply our policies
when evaluating genetic test results found in the medical evidence of
record (MER).
nce of a medically determinable
impairment (MDI). Genetic test results sometimes are a part of this
objective medical evidence and can also be of value at other points in
the sequential evaluation process. In this ruling, we provide basic
information about genetic testing and clarify how we apply our policies
when evaluating genetic test results found in the medical evidence of
record (MER).

POLICY INTERPRETATION: We consider all medical evidence, including
genetic test results, when evaluating a claim for disability benefits.
The information that follows is presented in question and answer format
and provides details about medical genetics and how to consider MER
containing genetic test results under our disability policy. Questions
1 through 3 provide basic background information about genetic tests and
their use in the medical setting. Question 4 discusses the relevance of
genetic test results to our disability program. Question 5 discusses
whether genetic test results alone are sufficient to make a disability
determination. Question 6 clarifies that we do not purchase genetic
testing. Questions 7 through 11 specify how adjudicators should handle
evidence containing genetic test results at various points of the
adjudication process. Question 12 addresses our policy on the
disclosure of genetic information.

List of Questions

- What is genetic
testing?

- How do genetic
variants relate to medical disorders?

- Why do medical
professionals order genetic tests?

- Why are genetic
tests relevant to us?

- Are genetic test
results alone sufficient to make a disability determination or
decision?

- Will we purchase
genetic testing by way of consultative examination (CE)?

- Do we consider
medical evidence that includes the results of genetic tests?

- Do we require
genetic test results to find a claimant disabled?

- Who typically provides
genetic test evidence?

- Can we consider
genetic test results in the sequential evaluation process?
disability determination or
decision?

- Will we purchase
genetic testing by way of consultative examination (CE)?

- Do we consider
medical evidence that includes the results of genetic tests?

- Do we require
genetic test results to find a claimant disabled?

- Who typically provides
genetic test evidence?

- Can we consider
genetic test results in the sequential evaluation process?

- If a person is
found disabled, can we use genetic test results when setting a diary for
continuing disability review (CDR)?

- What is our policy
regarding the disclosure of the results of genetic tests?

What is genetic
testing?

How do genetic
variants relate to medical disorders?

Why do medical
professionals order genetic tests?

Why are genetic
tests relevant to us?

Are genetic test
results alone sufficient to make a disability determination or
decision?

Will we purchase
genetic testing by way of consultative examination (CE)?

Do we consider
medical evidence that includes the results of genetic tests?

Do we require
genetic test results to find a claimant disabled?

Who typically provides
genetic test evidence?

Can we consider
genetic test results in the sequential evaluation process?

If a person is
found disabled, can we use genetic test results when setting a diary for
continuing disability review (CDR)?

What is our policy
regarding the disclosure of the results of genetic tests?

Answers
ire
genetic test results to find a claimant disabled?

Who typically provides
genetic test evidence?

Can we consider
genetic test results in the sequential evaluation process?

If a person is
found disabled, can we use genetic test results when setting a diary for
continuing disability review (CDR)?

What is our policy
regarding the disclosure of the results of genetic tests?

Answers

- What is genetic testing? [2] Genetic testing is a type of medical
test that identifies variations in genetic material. Genetic testing
uses laboratory methods to detect genetic variations associated with a
disease, condition, or genetic disorder. For the purposes of this
ruling, we will consider tests that analyze chromosomes , deoxyribonucleic acid (DNA), or ribonucleic acid (RNA) for
the purpose of identifying congenital genetic variations to be genetic
tests. [3] Different types of laboratory tests constitute genetic tests.
For example, karyotyping , which counts and examines the
appearance of chromosomes in a cell, is a type of genetic test. Some
other types of genetic tests read and evaluate the sequence of the
nucleotide bases that make up a DNA molecule or examine changes at one
specific place in the genome. Differences from the normal (or
reference) sequence are known as mutations or variants. Variants also
encompass partial or complete loss or gain of gene copies.

- How do genetic variants relate to
medical disorders? People generally have two copies of every gene in their body, one
contributed by their biological mother, the other contributed by their
biological father. Some disorders are caused by a variation in a single
gene. In certain cases, having a variation in just one of the two
copies of the gene is enough to lead to a disorder. If a variant's
occurrence in only one copy of the gene is sufficient for a person to
develop the disorder, the disorder is dominant
contributed by their biological mother, the other contributed by their
biological father. Some disorders are caused by a variation in a single
gene. In certain cases, having a variation in just one of the two
copies of the gene is enough to lead to a disorder. If a variant's
occurrence in only one copy of the gene is sufficient for a person to
develop the disorder, the disorder is dominant . The disorder is recessive if an associated variant must occur in both copies of
the gene for a person to develop the disorder. Even when a person knows that he or she has a genetic variant
associated with or causative of a certain disorder, he or she may not
always develop the condition. Penetrance is the term that
describes the frequency with which people in a population with a given
genetic variant actually display signs and symptoms of the associated
disorder. It is often expressed as a percentage. Complete
penetrance indicates that all people in a population with the
genetic variant will develop the disorder. Incomplete or reduced penetrance , which is far more common, means that only
some people in a population with the variant will actually get the
disorder. The probability that a given person will have a disorder
given that they have the variant is known as risk or chance . Variants can interact either with one another or with environmental
influences (such as ultraviolet light, diet, or smoking) to result in a
disorder. These types of disorders are called complex or multifactorial disorders. Even when genetic variants associated
with complex disorders are known, it may be difficult to determine the
risk of developing such disorders based on genetic test results. For
example, changes in a person's exposure to relevant environmental
influences can modify the risk of developing a disease or the severity
of a genetic condition. Chromosomal abnormalities can lead to disorders as well. A
chromosome is an organized package of DNA located in the nucleus of a
cell
be difficult to determine the
risk of developing such disorders based on genetic test results. For
example, changes in a person's exposure to relevant environmental
influences can modify the risk of developing a disease or the severity
of a genetic condition. Chromosomal abnormalities can lead to disorders as well. A
chromosome is an organized package of DNA located in the nucleus of a
cell. People generally have 2 copies of each of 23 chromosomes in their
cells. Aneuploidy means an incorrect number of chromosomes.
Down syndrome is an example of a genetic disorder caused by aneuploidy.
It is the result of a person having an extra copy of chromosome 21 in
some or all of his or her cells. A defect in a chromosome's structure
may also cause a genetic condition. Cri du chat syndrome is an example
of a disorder that results from a structural chromosomal abnormality.
It is due to one chromosome 5 missing a part.

- Why do medical professionals order
genetic tests? Like other laboratory tests or procedures, genetic tests can help
medical professionals diagnose a particular disease or disorder. They
assist in predicting the extent of disease features or risk of
developing a certain disorder, aid in therapy, and provide useful
information for reproductive purposes. Diagnostic tests Medical professionals may use genetic tests to diagnose a particular
disorder. They will usually order or perform these tests when a person
has medical signs or symptoms consistent with that disorder and a link
between specific genetic variations and the disorder is
well-characterized. They may also use testing when a disorder is
present but unrecognized (or undiagnosed) to work through a list of
possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests. Hemochromatosis is an example of a
disease for which medical professionals use a diagnostic genetic test to
help confirm a diagnosis
tic variations and the disorder is
well-characterized. They may also use testing when a disorder is
present but unrecognized (or undiagnosed) to work through a list of
possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests. Hemochromatosis is an example of a
disease for which medical professionals use a diagnostic genetic test to
help confirm a diagnosis. [4] Predictive tests A person might choose to have a genetic test even if he or she does
not have medical signs or symptoms indicative of a disorder. Instead,
he or she may undergo testing to find out whether he or she has a
genetic variant that might put him or her at risk for developing a
disorder in the future. This type of test is a predictive genetic test. A positive predictive test result may result in a
pre-symptomatic diagnosis of a genetic condition, or just knowledge of
an increased risk of developing that condition. Examples of predictive
genetic tests are those looking for variations in the genes BRCA1 and BRCA2 , which assess a person's risk for certain inherited
breast and ovarian cancer syndromes. [5] It is important to note that, for many conditions, predictive genetic
tests cannot tell with certainty whether a person will develop a
disorder. The results of predictive genetic tests generally give a
probability or range of probabilities that a disorder will eventually
develop in the person being tested. Predictive genetic tests also
generally cannot tell a person precisely how the disorder will affect
him or her. Many times, predictive genetic testing is most helpful when
a person has a known family history of a disease, and not knowing the
disease risk would lead to serious consequences. A person may choose to
undergo predictive genetic testing to make decisions about future
medical care or to implement lifestyle changes to help mitigate
potential risk for adverse health effects
l affect
him or her. Many times, predictive genetic testing is most helpful when
a person has a known family history of a disease, and not knowing the
disease risk would lead to serious consequences. A person may choose to
undergo predictive genetic testing to make decisions about future
medical care or to implement lifestyle changes to help mitigate
potential risk for adverse health effects. Pharmacogenetic tests Medical professionals might order pharmacogenetic tests for a
patient who needs to receive pharmaceutical therapy for his or her
disorder. The information from this kind of genetic test can help
medical staff understand how a patient may react to a particular drug
and assist in selection of the safest, most effective type and dosage of
medicine for that specific person. Tests for reproductive purposes There are genetic tests that people obtain prior to having a child in
order to inform them about the potential for a genetic disorder in their
child. These reproductive genetic tests include carrier tests, prenatal tests, and predictive tests for a late-onset
dominant disorder in an at-risk parent. [6] Carrier genetic tests are
performed on people who display no symptoms for a genetic disorder but
may be at risk for passing it on to their children. Diagnostic prenatal
genetic tests show if the developing baby has a certain genetic
condition. A parent with a family history of a genetic disorder with
dominant inheritance that does not manifest until after childbearing
years may wish to get a predictive genetic test for that disorder to
understand the risk of passing that disorder to his or her child.
k for passing it on to their children. Diagnostic prenatal
genetic tests show if the developing baby has a certain genetic
condition. A parent with a family history of a genetic disorder with
dominant inheritance that does not manifest until after childbearing
years may wish to get a predictive genetic test for that disorder to
understand the risk of passing that disorder to his or her child.

- Why are genetic tests relevant
to us? Scientific researchers are discovering an increasing number of
associations between genetic variants and medical disorders. [7] With this
knowledge often comes the ability to perform a laboratory test to
determine whether a person carries a genetic variation associated with a
particular disorder. There are tens of thousands of genetic tests
available for clinical use and the number continues to grow. These
tests can identify thousands of genetic disorders. [8] The results of such
tests may appear in disability case records. Genetic tests are more
widely available and genetic test results are now more commonplace
within disability case files.

- Are genetic test results alone
sufficient to make a disability determination or decision? With the sole exception of non-mosaic Down syndrome, genetic test
results alone are not sufficient to make a disability determination or
decision. A person may be found disabled based on meeting the criteria
for non-mosaic Down syndrome in the Listing of Impairments (listings)
under 10.06A and 110.06A, when this condition is documented by a
karyotype report signed by a physician. [9] Genetic test results alone are
otherwise not sufficient to make a disability determination; however, in
two other medical listings, we use genetic test results as part of the
criteria to evaluate whether a person's impairment meets the listing. [10] Additional evidence, including signs and symptoms of a person's
impairment, is generally necessary to make a disability determination
ysician. [9] Genetic test results alone are
otherwise not sufficient to make a disability determination; however, in
two other medical listings, we use genetic test results as part of the
criteria to evaluate whether a person's impairment meets the listing. [10] Additional evidence, including signs and symptoms of a person's
impairment, is generally necessary to make a disability determination.
As genetic testing continues to advance, we will consider appropriate
changes to our program policy.

- Will we purchase genetic testing
by way of consultative examination (CE)? No. We will not order genetic testing in a CE. While genetic test
results may provide valuable information when they appear as part of a
large body of MER, they are not necessary to establish a finding of
disability.

- Do we consider medical evidence that
includes the results of genetic tests? Yes, we consider all evidence we receive, including genetic test
results, when evaluating a disability claim. [11] In considering a
disability claim, we generally request evidence about a person's medical
impairment(s) for a period of at least the 12 months (and a longer
duration if circumstances warrant) preceding the month in which a person
files an application. [12] This includes objective medical evidence, a
claimant's reported symptoms, statements from others about the effects
of the claimant's impairment(s), and opinion evidence. [13] The results of genetic tests constitute laboratory findings, which
are considered objective medical evidence. Consistent with our
regulations, when genetic test results are available, we will consider
them, together with all relevant evidence available in the case record,
such as signs, symptoms, other laboratory findings, and medical opinion
evidence. [14] When evidence is inconsistent, such as when genetic test
results are inconsistent with other substantial evidence, we will
resolve the inconsistency when it is material to the disability
determination, as we do with all medical evidence
them, together with all relevant evidence available in the case record,
such as signs, symptoms, other laboratory findings, and medical opinion
evidence. [14] When evidence is inconsistent, such as when genetic test
results are inconsistent with other substantial evidence, we will
resolve the inconsistency when it is material to the disability
determination, as we do with all medical evidence. [15]

- Do we require genetic test results
to find a claimant disabled? No, genetic test results are not required for a finding of
disability. A finding of disability requires a claimant to have an MDI,
which can be expected to result in death or which has lasted or can be
expected to last for a continuing period of not less than 12 months. [16] We
establish physical and mental impairments by medical evidence consisting
of signs, symptoms, and laboratory findings. [17] While several medical
listings require or reference the use of genetic test results as a way
to meet the applicable listing at step 3 of the sequential evaluation
process, [18] our rules do not require the results of genetic tests in order
to determine that a person is disabled.

- Who typically provides genetic test
evidence? We typically receive the results of genetic tests in medical evidence
from clinical geneticists, other physicians, and genetic counselors.
Claimants sometimes provide results of “direct-to-consumer”
(DTC) medical tests. We will consider genetic test results from all
sources, medical and otherwise. [19] Geneticists and other physicians Clinical geneticists are physicians specializing in the diagnosis
and management of hereditary disorders. Clinical geneticists and other
licensed physicians have a medical degree and are acceptable medical
sources (AMS). We establish the existence of an MDI using objective
medical evidence (signs or laboratory results) from an AMS.
Cytogeneticists, biochemical geneticists, and molecular geneticists may
hold a Ph.D. or a medical degree (e.g., M.D
diagnosis
and management of hereditary disorders. Clinical geneticists and other
licensed physicians have a medical degree and are acceptable medical
sources (AMS). We establish the existence of an MDI using objective
medical evidence (signs or laboratory results) from an AMS.
Cytogeneticists, biochemical geneticists, and molecular geneticists may
hold a Ph.D. or a medical degree (e.g., M.D. or D.O.); those without a
medical degree are generally not AMSs. For example, Ph.D.
cytogeneticists typically work in laboratories or act as clinical
consultants, but do not regularly interact with patients. These types
of geneticists may be involved in obtaining genetic testing results and
may be board-certified, but they are not AMSs if they are not also
licensed physicians or otherwise classified as an AMS. Genetic counselors Genetic counselors assess and communicate genetic risk for medical
conditions in a person and members of his or her biological family.
They obtain and evaluate personal and family medical histories as well
as identify and coordinate genetic tests and other diagnostic studies,
as appropriate, to obtain needed information for a genetic assessment.
They are also able to explain the clinical implications of genetic
laboratory tests and other diagnostic studies and their results. [20] These professionals typically hold a master's degree in Genetic
Counseling and may be board-certified by the American Board of Genetic
Counseling (denoted by the use of the credential “Certified
Genetic Counselor” or CGC). However, we do not consider a genetic
counselor to be an AMS under our rules unless the individual is also a
licensed physician or other AMS provider. This is true even when the
genetic counselor is licensed to practice genetic counseling by his or
her State. We cannot establish the existence of an MDI based solely on
a report from a genetic counselor
l “Certified
Genetic Counselor” or CGC). However, we do not consider a genetic
counselor to be an AMS under our rules unless the individual is also a
licensed physician or other AMS provider. This is true even when the
genetic counselor is licensed to practice genetic counseling by his or
her State. We cannot establish the existence of an MDI based solely on
a report from a genetic counselor. We can use evidence from genetic
counselors working in an independent capacity to show the severity of a
person's impairment and how it affects the person's ability to work, or,
for children, how the child typically functions compared to children of
the same age who do not have impairments. [21] “Direct-to-consumer” (DTC) tests DTC genetic tests are available and appear to be growing in
popularity. These tests are generally marketed directly to consumers
via television, print advertisements, or the internet. A person
typically collects a DNA sample at home, such as by swabbing the inside
of the cheek, and mails the sample back to the laboratory for testing.
In some cases, the person must visit a health clinic to have blood
drawn. The samples are analyzed and consumers are directly notified of
the results by mail, over the telephone, or online. [22] There is currently little regulation and oversight of DTC genetic
testing, leading to concerns about its accuracy, reliability, and
clinical relevance. [23] DTC services generally do not establish an
appropriate chain of custody of the DNA sample. There is no assurance
that DTC genetic test results belong to a given claimant, as the entire
transaction typically takes place with no personal interaction with a
medical source or without any type of oversight that confirms the
identity of the person providing the sample. For these reasons, DTC
genetic test results cannot be the basis for establishing an MDI,
regardless of AMS adoption or involvement
assurance
that DTC genetic test results belong to a given claimant, as the entire
transaction typically takes place with no personal interaction with a
medical source or without any type of oversight that confirms the
identity of the person providing the sample. For these reasons, DTC
genetic test results cannot be the basis for establishing an MDI,
regardless of AMS adoption or involvement. [24] Nevertheless, DTC results,
when consistent with independent credible objective medical evidence,
can help corroborate other findings or the claimant's allegations. [25]

- Can we consider genetic test
results in the sequential evaluation process? Yes, we consider genetic test results and all other evidence in
varying ways throughout the sequential evaluation process. [26] At step 2 we
establish whether a person has an MDI and whether the impairment or
combination of impairments is severe, i.e., whether it significantly
limits the physical or mental ability to do basic work activities. [27] Information from genetic test results can help establish an MDI if they
are from an AMS and not based on DTC test results. However, a genetic
test alone cannot typically show whether or not an impairment is severe.
At step 3 we consider whether the impairment meets or medically equals
the requirements of a listed impairment in the medical listings.
Several of our medical listings include criteria that require
appropriate genetic test results for an impairment to meet the listing. [28] If a person's MDI does not meet or medically equal a listing, we
assess whether the impairment(s) results in functional limitations that
would prevent him or her from performing past relevant work or other
work at steps 4 and 5 of sequential evaluation. [29] For children, we assess
whether the impairment(s) causes marked and severe functional
limitations. [30] Genetic test results generally do not provide us with
significant information about impairment severity or functional
capacities
results in functional limitations that
would prevent him or her from performing past relevant work or other
work at steps 4 and 5 of sequential evaluation. [29] For children, we assess
whether the impairment(s) causes marked and severe functional
limitations. [30] Genetic test results generally do not provide us with
significant information about impairment severity or functional
capacities. Can we use genetic test results to establish an MDI (Step 2)? When genetic test results come from an AMS and are not based on DTC
genetic testing, we can use the evidence to establish an MDI if there
are signs and symptoms consistent with the impairment. [31] We can consider
the results of previously-performed genetic testing in establishing an
MDI, if signs and symptoms of an impairment are present. We cannot use
the results of genetic tests, in the absence of any signs or symptoms,
as the sole basis for establishing an MDI, even if the results are
highly- suggestive of the eventual development of an impairment. [32] We
must be able to establish that a person has an MDI at the disability
onset date. Although non-physician geneticists are generally not AMSs, a
physician or other AMS typically reviews or evaluates test results
produced by a non-physician geneticist and incorporates these test
results into an individual's medical record. In such a case, the
evidence can be used to help establish an MDI. Similarly, genetic
counselors are generally not AMSs. Therefore, we cannot establish the
existence of an MDI based solely on a report from a genetic counselor.
However, genetic counselors typically work in a setting where they are
in close collaboration with a physician or other AMS. When a person is
referred for diagnostic testing by a genetic counselor, the results are
often reviewed, evaluated, interpreted, or used by a physician and
incorporated into a medical record. In such a case, this evidence can
help establish an MDI
a genetic counselor.
However, genetic counselors typically work in a setting where they are
in close collaboration with a physician or other AMS. When a person is
referred for diagnostic testing by a genetic counselor, the results are
often reviewed, evaluated, interpreted, or used by a physician and
incorporated into a medical record. In such a case, this evidence can
help establish an MDI. Similar to imaging from an x-ray or MRI, which requires AMS
involvement to establish an MDI, a genetic test result without AMS
involvement cannot establish an MDI. A DTC genetic test result, even if
evaluated, interpreted, or otherwise utilized by an AMS, cannot lead to
the establishment of an MDI because there is no assurance that the test
results belong to a given claimant and no appropriate chain of custody
of the sample is established. Many disorders with a known genetic basis can be, and often are,
established by means other than genetic tests. For example, although
diagnostic genetic tests for cystic fibrosis exist, as do guidelines
surrounding their use, the most common confirmatory test for this
disease is the sweat chloride test, which measures the concentrations of
a certain electrolyte in a person's sweat. [33] It is not a genetic test.
While we consider genetic test results in conjunction with the rest of
the objective medical evidence when they are available, we do not
require a person to undergo such testing to prove they have an MDI or
are disabled. Can we evaluate impairment severity using the results of genetic
tests (Step 2)? To some extent, genetic test results can be helpful in our overall
impairment evaluation, but generally they do not help us determine
whether or not an impairment is severe. For an impairment to be severe,
it must significantly limit an adult's physical or mental ability to do
basic work activities. [34] In the case of a child, for an impairment to be
severe it must be more than a slight abnormality that causes more than
minimal functional limitations
erall
impairment evaluation, but generally they do not help us determine
whether or not an impairment is severe. For an impairment to be severe,
it must significantly limit an adult's physical or mental ability to do
basic work activities. [34] In the case of a child, for an impairment to be
severe it must be more than a slight abnormality that causes more than
minimal functional limitations. [35] Genetic test results generally do not provide information about the
degree of functional limitation associated with an impairment, but they
can be used to help evaluate for consistency with or supportability of
alleged symptoms and limitations. With the exception of non-mosaic Down
Syndrome, we need evidence other than genetic test results to show a
person's impairment is severe. This evidence comes from other medical
records, a claimant's report of symptoms, and statements from nonmedical
sources. [36] Can we evaluate medical listings with genetic test results (Step
3)? For several medical listings, we use genetic test results to evaluate
whether a person's impairment meets a medical listing. Four of our
medical listings include, as part of the criteria for an impairment to
meet a listing, the use of appropriate genetic test results. [37] Listings
10.06 and 110.06 for non-mosaic Down syndrome (trisomy 21) use the
results of genetic tests. Karyotyping for Down syndrome is the
“gold standard” for diagnosis. We typically require the
results of karyotype analysis for an impairment to meet 10.06A, 10.06B,
110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test
results for xeroderma pigmentosum to meet listing 8.07A or 108.07A. We may also use genetic test results indicating the presence of a
catastrophic congenital disorder, such as Edward's syndrome (trisomy
18), to find a child's impairment meets listing 110.08
of karyotype analysis for an impairment to meet 10.06A, 10.06B,
110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test
results for xeroderma pigmentosum to meet listing 8.07A or 108.07A. We may also use genetic test results indicating the presence of a
catastrophic congenital disorder, such as Edward's syndrome (trisomy
18), to find a child's impairment meets listing 110.08. Other medical
listings are for disorders, such as cystic fibrosis [39] and chronic
myelogenous leukemia, with at least one known genetic basis and an
available associated test. [40] Often, additional medical evidence is
required to find a person's impairment meets a relevant listing. [41] Can we evaluate the degree of limitation and residual functional
capacity (RFC) using genetic test results (Steps 4 and 5)? While genetic tests may help to establish the presence of a disorder
and assist in determining whether an impairment meets or medically
equals a listing, the results alone generally do not provide us with
information about the degree of a person's limitation due to the
impairment. A claimant's RFC reflects the most he or she can do despite
his or her limitations. [42] If an adult's impairment does not meet or
medically equal a listing at step 3 of the sequential evaluation
process, we assess RFC, which applies to both steps 4 and 5. If a
child's impairment does not meet or medically equal a listing, we assess
functional equivalence. Functional equivalence deals with broad areas
of functioning intended to capture all of what a child can or cannot
do. [43] As is the case with RFC, genetic test results alone generally do not
provide us with information about the degree of limitation as it relates
to functional equivalence. To assess a claimant's impairments beyond step 3, we need non-genetic
evidence about the impairment's effect on a person's functioning to
determine the most the person can do despite his or her limitations and
restrictions
43] As is the case with RFC, genetic test results alone generally do not
provide us with information about the degree of limitation as it relates
to functional equivalence. To assess a claimant's impairments beyond step 3, we need non-genetic
evidence about the impairment's effect on a person's functioning to
determine the most the person can do despite his or her limitations and
restrictions. [44] Many disorders associated with known gene mutations are
multifactorial in nature. Environmental and other influences that are
not well-understood affect the development of medical signs and symptoms
resulting from the disorder and the degree of limitation a person with
the disorder experiences. Therefore, additional evidence is necessary
to adequately assess a person's RFC and ability to engage in work
activities. However, results of genetic tests can be assessed for consistency
with a person's symptoms and alleged limitations. For example, genetic
test results may lead an AMS to diagnose familial Mediterranean fever.
A common symptom is painful inflammation in various areas of the body,
including joints. [45] If someone complains of significant joint pain
and has genetic test results leading to a diagnosis of familial
Mediterranean fever, we can take into account that the claimant's
reported symptoms are consistent with the genetic test results.

- If a person is found disabled,
can we use genetic test results
when setting a diary for continuing disability review (CDR)? Yes. We consider all impairments and case facts to determine when to
conduct a CDR. We conduct a full evaluation of all evidence, including
genetic test results, when setting diary dates. Due to the diversity of
types of genetic tests and the differing types of information that
genetic test results can provide, the impact of genetic test results on
diary lengths will vary.
ility review (CDR)? Yes. We consider all impairments and case facts to determine when to
conduct a CDR. We conduct a full evaluation of all evidence, including
genetic test results, when setting diary dates. Due to the diversity of
types of genetic tests and the differing types of information that
genetic test results can provide, the impact of genetic test results on
diary lengths will vary.

- What is our policy regarding the
disclosure of the results of genetic tests? The Privacy Act of 1974 (5 U.S.C. 552a), section 1106 of the Social
Security Act (42 U.S.C. 1306), and our disclosure regulations ( 20 CFR Part
401 ) govern the collection, maintenance, and use of an individual's
information in our systems of records. Although these authorities do
not specifically address requirements for the disclosure of genetic test
results, they apply to the extent we maintain this type of information
in our records. Under the Privacy Act and our disclosure regulations, we generally
cannot disclose genetic test results without the consent of the subject
of the record. For example, if an individual's MER contains genetic
test results and he or she authorizes us to disclose this specific
information to a third party, we will do so with a valid, written
consent that meets our regulatory requirements. In addition, the Privacy Act grants individuals a right of access to
any records we maintain about them in our systems of records.
Therefore, any genetic test results we maintain in an individual's MER
(including records a medical consultative examiner may have generated on
our behalf) are subject to these access requirements, as is the case
with all medical evidence. However, if we determine that direct access
to the medical information is likely to have an adverse effect on the
subject of the record, we will follow certain procedures in providing
access to the information. [46]

What is genetic testing? [2]
a medical consultative examiner may have generated on
our behalf) are subject to these access requirements, as is the case
with all medical evidence. However, if we determine that direct access
to the medical information is likely to have an adverse effect on the
subject of the record, we will follow certain procedures in providing
access to the information. [46]

What is genetic testing? [2]

Genetic testing is a type of medical
test that identifies variations in genetic material. Genetic testing
uses laboratory methods to detect genetic variations associated with a
disease, condition, or genetic disorder. For the purposes of this
ruling, we will consider tests that analyze chromosomes , deoxyribonucleic acid (DNA), or ribonucleic acid (RNA) for
the purpose of identifying congenital genetic variations to be genetic
tests. [3] Different types of laboratory tests constitute genetic tests.
For example, karyotyping , which counts and examines the
appearance of chromosomes in a cell, is a type of genetic test. Some
other types of genetic tests read and evaluate the sequence of the
nucleotide bases that make up a DNA molecule or examine changes at one
specific place in the genome. Differences from the normal (or
reference) sequence are known as mutations or variants. Variants also
encompass partial or complete loss or gain of gene copies.

How do genetic variants relate to
medical disorders?

People generally have two copies of every gene in their body, one
contributed by their biological mother, the other contributed by their
biological father. Some disorders are caused by a variation in a single
gene. In certain cases, having a variation in just one of the two
copies of the gene is enough to lead to a disorder. If a variant's
occurrence in only one copy of the gene is sufficient for a person to
develop the disorder, the disorder is dominant . The disorder is recessive if an associated variant must occur in both copies of
the gene for a person to develop the disorder.
tion in a single
gene. In certain cases, having a variation in just one of the two
copies of the gene is enough to lead to a disorder. If a variant's
occurrence in only one copy of the gene is sufficient for a person to
develop the disorder, the disorder is dominant . The disorder is recessive if an associated variant must occur in both copies of
the gene for a person to develop the disorder.

Even when a person knows that he or she has a genetic variant
associated with or causative of a certain disorder, he or she may not
always develop the condition. Penetrance is the term that
describes the frequency with which people in a population with a given
genetic variant actually display signs and symptoms of the associated
disorder. It is often expressed as a percentage. Complete
penetrance indicates that all people in a population with the
genetic variant will develop the disorder. Incomplete or reduced penetrance , which is far more common, means that only
some people in a population with the variant will actually get the
disorder. The probability that a given person will have a disorder
given that they have the variant is known as risk or chance .

Variants can interact either with one another or with environmental
influences (such as ultraviolet light, diet, or smoking) to result in a
disorder. These types of disorders are called complex or multifactorial disorders. Even when genetic variants associated
with complex disorders are known, it may be difficult to determine the
risk of developing such disorders based on genetic test results. For
example, changes in a person's exposure to relevant environmental
influences can modify the risk of developing a disease or the severity
of a genetic condition.
isorders are called complex or multifactorial disorders. Even when genetic variants associated
with complex disorders are known, it may be difficult to determine the
risk of developing such disorders based on genetic test results. For
example, changes in a person's exposure to relevant environmental
influences can modify the risk of developing a disease or the severity
of a genetic condition.

Chromosomal abnormalities can lead to disorders as well. A
chromosome is an organized package of DNA located in the nucleus of a
cell. People generally have 2 copies of each of 23 chromosomes in their
cells. Aneuploidy means an incorrect number of chromosomes.
Down syndrome is an example of a genetic disorder caused by aneuploidy.
It is the result of a person having an extra copy of chromosome 21 in
some or all of his or her cells. A defect in a chromosome's structure
may also cause a genetic condition. Cri du chat syndrome is an example
of a disorder that results from a structural chromosomal abnormality.
It is due to one chromosome 5 missing a part.

Why do medical professionals order
genetic tests?

Like other laboratory tests or procedures, genetic tests can help
medical professionals diagnose a particular disease or disorder. They
assist in predicting the extent of disease features or risk of
developing a certain disorder, aid in therapy, and provide useful
information for reproductive purposes.

- Diagnostic tests Medical professionals may use genetic tests to diagnose a particular
disorder. They will usually order or perform these tests when a person
has medical signs or symptoms consistent with that disorder and a link
between specific genetic variations and the disorder is
well-characterized. They may also use testing when a disorder is
present but unrecognized (or undiagnosed) to work through a list of
possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests
rder or perform these tests when a person
has medical signs or symptoms consistent with that disorder and a link
between specific genetic variations and the disorder is
well-characterized. They may also use testing when a disorder is
present but unrecognized (or undiagnosed) to work through a list of
possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests. Hemochromatosis is an example of a
disease for which medical professionals use a diagnostic genetic test to
help confirm a diagnosis. [4]

- Predictive tests A person might choose to have a genetic test even if he or she does
not have medical signs or symptoms indicative of a disorder. Instead,
he or she may undergo testing to find out whether he or she has a
genetic variant that might put him or her at risk for developing a
disorder in the future. This type of test is a predictive genetic test. A positive predictive test result may result in a
pre-symptomatic diagnosis of a genetic condition, or just knowledge of
an increased risk of developing that condition. Examples of predictive
genetic tests are those looking for variations in the genes BRCA1 and BRCA2 , which assess a person's risk for certain inherited
breast and ovarian cancer syndromes. [5] It is important to note that, for many conditions, predictive genetic
tests cannot tell with certainty whether a person will develop a
disorder. The results of predictive genetic tests generally give a
probability or range of probabilities that a disorder will eventually
develop in the person being tested. Predictive genetic tests also
generally cannot tell a person precisely how the disorder will affect
him or her. Many times, predictive genetic testing is most helpful when
a person has a known family history of a disease, and not knowing the
disease risk would lead to serious consequences
probability or range of probabilities that a disorder will eventually
develop in the person being tested. Predictive genetic tests also
generally cannot tell a person precisely how the disorder will affect
him or her. Many times, predictive genetic testing is most helpful when
a person has a known family history of a disease, and not knowing the
disease risk would lead to serious consequences. A person may choose to
undergo predictive genetic testing to make decisions about future
medical care or to implement lifestyle changes to help mitigate
potential risk for adverse health effects.

- Pharmacogenetic tests Medical professionals might order pharmacogenetic tests for a
patient who needs to receive pharmaceutical therapy for his or her
disorder. The information from this kind of genetic test can help
medical staff understand how a patient may react to a particular drug
and assist in selection of the safest, most effective type and dosage of
medicine for that specific person.

- Tests for reproductive purposes There are genetic tests that people obtain prior to having a child in
order to inform them about the potential for a genetic disorder in their
child. These reproductive genetic tests include carrier tests, prenatal tests, and predictive tests for a late-onset
dominant disorder in an at-risk parent. [6] Carrier genetic tests are
performed on people who display no symptoms for a genetic disorder but
may be at risk for passing it on to their children. Diagnostic prenatal
genetic tests show if the developing baby has a certain genetic
condition. A parent with a family history of a genetic disorder with
dominant inheritance that does not manifest until after childbearing
years may wish to get a predictive genetic test for that disorder to
understand the risk of passing that disorder to his or her child.

Diagnostic tests
n to their children. Diagnostic prenatal
genetic tests show if the developing baby has a certain genetic
condition. A parent with a family history of a genetic disorder with
dominant inheritance that does not manifest until after childbearing
years may wish to get a predictive genetic test for that disorder to
understand the risk of passing that disorder to his or her child.

Diagnostic tests

Medical professionals may use genetic tests to diagnose a particular
disorder. They will usually order or perform these tests when a person
has medical signs or symptoms consistent with that disorder and a link
between specific genetic variations and the disorder is
well-characterized. They may also use testing when a disorder is
present but unrecognized (or undiagnosed) to work through a list of
possibilities, i.e., differential diagnoses. Such tests are known as diagnostic genetic tests. Hemochromatosis is an example of a
disease for which medical professionals use a diagnostic genetic test to
help confirm a diagnosis. [4]

Predictive tests

A person might choose to have a genetic test even if he or she does
not have medical signs or symptoms indicative of a disorder. Instead,
he or she may undergo testing to find out whether he or she has a
genetic variant that might put him or her at risk for developing a
disorder in the future. This type of test is a predictive genetic test. A positive predictive test result may result in a
pre-symptomatic diagnosis of a genetic condition, or just knowledge of
an increased risk of developing that condition. Examples of predictive
genetic tests are those looking for variations in the genes BRCA1 and BRCA2 , which assess a person's risk for certain inherited
breast and ovarian cancer syndromes. [5]
test is a predictive genetic test. A positive predictive test result may result in a
pre-symptomatic diagnosis of a genetic condition, or just knowledge of
an increased risk of developing that condition. Examples of predictive
genetic tests are those looking for variations in the genes BRCA1 and BRCA2 , which assess a person's risk for certain inherited
breast and ovarian cancer syndromes. [5]

It is important to note that, for many conditions, predictive genetic
tests cannot tell with certainty whether a person will develop a
disorder. The results of predictive genetic tests generally give a
probability or range of probabilities that a disorder will eventually
develop in the person being tested. Predictive genetic tests also
generally cannot tell a person precisely how the disorder will affect
him or her. Many times, predictive genetic testing is most helpful when
a person has a known family history of a disease, and not knowing the
disease risk would lead to serious consequences. A person may choose to
undergo predictive genetic testing to make decisions about future
medical care or to implement lifestyle changes to help mitigate
potential risk for adverse health effects.

Pharmacogenetic tests

Medical professionals might order pharmacogenetic tests for a
patient who needs to receive pharmaceutical therapy for his or her
disorder. The information from this kind of genetic test can help
medical staff understand how a patient may react to a particular drug
and assist in selection of the safest, most effective type and dosage of
medicine for that specific person.

Tests for reproductive purposes
ofessionals might order pharmacogenetic tests for a
patient who needs to receive pharmaceutical therapy for his or her
disorder. The information from this kind of genetic test can help
medical staff understand how a patient may react to a particular drug
and assist in selection of the safest, most effective type and dosage of
medicine for that specific person.

Tests for reproductive purposes

There are genetic tests that people obtain prior to having a child in
order to inform them about the potential for a genetic disorder in their
child. These reproductive genetic tests include carrier tests, prenatal tests, and predictive tests for a late-onset
dominant disorder in an at-risk parent. [6] Carrier genetic tests are
performed on people who display no symptoms for a genetic disorder but
may be at risk for passing it on to their children. Diagnostic prenatal
genetic tests show if the developing baby has a certain genetic
condition. A parent with a family history of a genetic disorder with
dominant inheritance that does not manifest until after childbearing
years may wish to get a predictive genetic test for that disorder to
understand the risk of passing that disorder to his or her child.

Why are genetic tests relevant
to us?

Scientific researchers are discovering an increasing number of
associations between genetic variants and medical disorders. [7] With this
knowledge often comes the ability to perform a laboratory test to
determine whether a person carries a genetic variation associated with a
particular disorder. There are tens of thousands of genetic tests
available for clinical use and the number continues to grow. These
tests can identify thousands of genetic disorders. [8] The results of such
tests may appear in disability case records. Genetic tests are more
widely available and genetic test results are now more commonplace
within disability case files.

Are genetic test results alone
sufficient to make a disability determination or decision?
ilable for clinical use and the number continues to grow. These
tests can identify thousands of genetic disorders. [8] The results of such
tests may appear in disability case records. Genetic tests are more
widely available and genetic test results are now more commonplace
within disability case files.

Are genetic test results alone
sufficient to make a disability determination or decision?

With the sole exception of non-mosaic Down syndrome, genetic test
results alone are not sufficient to make a disability determination or
decision. A person may be found disabled based on meeting the criteria
for non-mosaic Down syndrome in the Listing of Impairments (listings)
under 10.06A and 110.06A, when this condition is documented by a
karyotype report signed by a physician. [9] Genetic test results alone are
otherwise not sufficient to make a disability determination; however, in
two other medical listings, we use genetic test results as part of the
criteria to evaluate whether a person's impairment meets the listing. [10] Additional evidence, including signs and symptoms of a person's
impairment, is generally necessary to make a disability determination.
As genetic testing continues to advance, we will consider appropriate
changes to our program policy.

Will we purchase genetic testing
by way of consultative examination (CE)?

No. We will not order genetic testing in a CE. While genetic test
results may provide valuable information when they appear as part of a
large body of MER, they are not necessary to establish a finding of
disability.

Do we consider medical evidence that
includes the results of genetic tests?
to our program policy.

Will we purchase genetic testing
by way of consultative examination (CE)?

No. We will not order genetic testing in a CE. While genetic test
results may provide valuable information when they appear as part of a
large body of MER, they are not necessary to establish a finding of
disability.

Do we consider medical evidence that
includes the results of genetic tests?

Yes, we consider all evidence we receive, including genetic test
results, when evaluating a disability claim. [11] In considering a
disability claim, we generally request evidence about a person's medical
impairment(s) for a period of at least the 12 months (and a longer
duration if circumstances warrant) preceding the month in which a person
files an application. [12] This includes objective medical evidence, a
claimant's reported symptoms, statements from others about the effects
of the claimant's impairment(s), and opinion evidence. [13]

The results of genetic tests constitute laboratory findings, which
are considered objective medical evidence. Consistent with our
regulations, when genetic test results are available, we will consider
them, together with all relevant evidence available in the case record,
such as signs, symptoms, other laboratory findings, and medical opinion
evidence. [14] When evidence is inconsistent, such as when genetic test
results are inconsistent with other substantial evidence, we will
resolve the inconsistency when it is material to the disability
determination, as we do with all medical evidence. [15]

Do we require genetic test results
to find a claimant disabled?
such as signs, symptoms, other laboratory findings, and medical opinion
evidence. [14] When evidence is inconsistent, such as when genetic test
results are inconsistent with other substantial evidence, we will
resolve the inconsistency when it is material to the disability
determination, as we do with all medical evidence. [15]

Do we require genetic test results
to find a claimant disabled?

No, genetic test results are not required for a finding of
disability. A finding of disability requires a claimant to have an MDI,
which can be expected to result in death or which has lasted or can be
expected to last for a continuing period of not less than 12 months. [16] We
establish physical and mental impairments by medical evidence consisting
of signs, symptoms, and laboratory findings. [17] While several medical
listings require or reference the use of genetic test results as a way
to meet the applicable listing at step 3 of the sequential evaluation
process, [18] our rules do not require the results of genetic tests in order
to determine that a person is disabled.

Who typically provides genetic test
evidence?

We typically receive the results of genetic tests in medical evidence
from clinical geneticists, other physicians, and genetic counselors.
Claimants sometimes provide results of “direct-to-consumer”
(DTC) medical tests. We will consider genetic test results from all
sources, medical and otherwise. [19]
r
to determine that a person is disabled.

Who typically provides genetic test
evidence?

We typically receive the results of genetic tests in medical evidence
from clinical geneticists, other physicians, and genetic counselors.
Claimants sometimes provide results of “direct-to-consumer”
(DTC) medical tests. We will consider genetic test results from all
sources, medical and otherwise. [19]

- Geneticists and other physicians Clinical geneticists are physicians specializing in the diagnosis
and management of hereditary disorders. Clinical geneticists and other
licensed physicians have a medical degree and are acceptable medical
sources (AMS). We establish the existence of an MDI using objective
medical evidence (signs or laboratory results) from an AMS.
Cytogeneticists, biochemical geneticists, and molecular geneticists may
hold a Ph.D. or a medical degree (e.g., M.D. or D.O.); those without a
medical degree are generally not AMSs. For example, Ph.D.
cytogeneticists typically work in laboratories or act as clinical
consultants, but do not regularly interact with patients. These types
of geneticists may be involved in obtaining genetic testing results and
may be board-certified, but they are not AMSs if they are not also
licensed physicians or otherwise classified as an AMS.

- Genetic counselors Genetic counselors assess and communicate genetic risk for medical
conditions in a person and members of his or her biological family.
They obtain and evaluate personal and family medical histories as well
as identify and coordinate genetic tests and other diagnostic studies,
as appropriate, to obtain needed information for a genetic assessment.
They are also able to explain the clinical implications of genetic
laboratory tests and other diagnostic studies and their results
person and members of his or her biological family.
They obtain and evaluate personal and family medical histories as well
as identify and coordinate genetic tests and other diagnostic studies,
as appropriate, to obtain needed information for a genetic assessment.
They are also able to explain the clinical implications of genetic
laboratory tests and other diagnostic studies and their results. [20] These professionals typically hold a master's degree in Genetic
Counseling and may be board-certified by the American Board of Genetic
Counseling (denoted by the use of the credential “Certified
Genetic Counselor” or CGC). However, we do not consider a genetic
counselor to be an AMS under our rules unless the individual is also a
licensed physician or other AMS provider. This is true even when the
genetic counselor is licensed to practice genetic counseling by his or
her State. We cannot establish the existence of an MDI based solely on
a report from a genetic counselor. We can use evidence from genetic
counselors working in an independent capacity to show the severity of a
person's impairment and how it affects the person's ability to work, or,
for children, how the child typically functions compared to children of
the same age who do not have impairments. [21]

- “Direct-to-consumer” (DTC) tests DTC genetic tests are available and appear to be growing in
popularity. These tests are generally marketed directly to consumers
via television, print advertisements, or the internet. A person
typically collects a DNA sample at home, such as by swabbing the inside
of the cheek, and mails the sample back to the laboratory for testing.
In some cases, the person must visit a health clinic to have blood
drawn. The samples are analyzed and consumers are directly notified of
the results by mail, over the telephone, or online. [22] There is currently little regulation and oversight of DTC genetic
testing, leading to concerns about its accuracy, reliability, and
clinical relevance
ls the sample back to the laboratory for testing.
In some cases, the person must visit a health clinic to have blood
drawn. The samples are analyzed and consumers are directly notified of
the results by mail, over the telephone, or online. [22] There is currently little regulation and oversight of DTC genetic
testing, leading to concerns about its accuracy, reliability, and
clinical relevance. [23] DTC services generally do not establish an
appropriate chain of custody of the DNA sample. There is no assurance
that DTC genetic test results belong to a given claimant, as the entire
transaction typically takes place with no personal interaction with a
medical source or without any type of oversight that confirms the
identity of the person providing the sample. For these reasons, DTC
genetic test results cannot be the basis for establishing an MDI,
regardless of AMS adoption or involvement. [24] Nevertheless, DTC results,
when consistent with independent credible objective medical evidence,
can help corroborate other findings or the claimant's allegations. [25]

Geneticists and other physicians

Clinical geneticists are physicians specializing in the diagnosis
and management of hereditary disorders. Clinical geneticists and other
licensed physicians have a medical degree and are acceptable medical
sources (AMS). We establish the existence of an MDI using objective
medical evidence (signs or laboratory results) from an AMS.
Cytogeneticists, biochemical geneticists, and molecular geneticists may
hold a Ph.D. or a medical degree (e.g., M.D. or D.O.); those without a
medical degree are generally not AMSs. For example, Ph.D.
cytogeneticists typically work in laboratories or act as clinical
consultants, but do not regularly interact with patients. These types
of geneticists may be involved in obtaining genetic testing results and
may be board-certified, but they are not AMSs if they are not also
licensed physicians or otherwise classified as an AMS.

Genetic counselors
ee are generally not AMSs. For example, Ph.D.
cytogeneticists typically work in laboratories or act as clinical
consultants, but do not regularly interact with patients. These types
of geneticists may be involved in obtaining genetic testing results and
may be board-certified, but they are not AMSs if they are not also
licensed physicians or otherwise classified as an AMS.

Genetic counselors

Genetic counselors assess and communicate genetic risk for medical
conditions in a person and members of his or her biological family.
They obtain and evaluate personal and family medical histories as well
as identify and coordinate genetic tests and other diagnostic studies,
as appropriate, to obtain needed information for a genetic assessment.
They are also able to explain the clinical implications of genetic
laboratory tests and other diagnostic studies and their results. [20]

These professionals typically hold a master's degree in Genetic
Counseling and may be board-certified by the American Board of Genetic
Counseling (denoted by the use of the credential “Certified
Genetic Counselor” or CGC). However, we do not consider a genetic
counselor to be an AMS under our rules unless the individual is also a
licensed physician or other AMS provider. This is true even when the
genetic counselor is licensed to practice genetic counseling by his or
her State. We cannot establish the existence of an MDI based solely on
a report from a genetic counselor. We can use evidence from genetic
counselors working in an independent capacity to show the severity of a
person's impairment and how it affects the person's ability to work, or,
for children, how the child typically functions compared to children of
the same age who do not have impairments. [21]

“Direct-to-consumer” (DTC) tests
nce of an MDI based solely on
a report from a genetic counselor. We can use evidence from genetic
counselors working in an independent capacity to show the severity of a
person's impairment and how it affects the person's ability to work, or,
for children, how the child typically functions compared to children of
the same age who do not have impairments. [21]

“Direct-to-consumer” (DTC) tests

DTC genetic tests are available and appear to be growing in
popularity. These tests are generally marketed directly to consumers
via television, print advertisements, or the internet. A person
typically collects a DNA sample at home, such as by swabbing the inside
of the cheek, and mails the sample back to the laboratory for testing.
In some cases, the person must visit a health clinic to have blood
drawn. The samples are analyzed and consumers are directly notified of
the results by mail, over the telephone, or online. [22]

There is currently little regulation and oversight of DTC genetic
testing, leading to concerns about its accuracy, reliability, and
clinical relevance. [23] DTC services generally do not establish an
appropriate chain of custody of the DNA sample. There is no assurance
that DTC genetic test results belong to a given claimant, as the entire
transaction typically takes place with no personal interaction with a
medical source or without any type of oversight that confirms the
identity of the person providing the sample. For these reasons, DTC
genetic test results cannot be the basis for establishing an MDI,
regardless of AMS adoption or involvement. [24] Nevertheless, DTC results,
when consistent with independent credible objective medical evidence,
can help corroborate other findings or the claimant's allegations. [25]

Can we consider genetic test
results in the sequential evaluation process?
the sample. For these reasons, DTC
genetic test results cannot be the basis for establishing an MDI,
regardless of AMS adoption or involvement. [24] Nevertheless, DTC results,
when consistent with independent credible objective medical evidence,
can help corroborate other findings or the claimant's allegations. [25]

Can we consider genetic test
results in the sequential evaluation process?

Yes, we consider genetic test results and all other evidence in
varying ways throughout the sequential evaluation process. [26] At step 2 we
establish whether a person has an MDI and whether the impairment or
combination of impairments is severe, i.e., whether it significantly
limits the physical or mental ability to do basic work activities. [27] Information from genetic test results can help establish an MDI if they
are from an AMS and not based on DTC test results. However, a genetic
test alone cannot typically show whether or not an impairment is severe.
At step 3 we consider whether the impairment meets or medically equals
the requirements of a listed impairment in the medical listings.
Several of our medical listings include criteria that require
appropriate genetic test results for an impairment to meet the listing. [28]

If a person's MDI does not meet or medically equal a listing, we
assess whether the impairment(s) results in functional limitations that
would prevent him or her from performing past relevant work or other
work at steps 4 and 5 of sequential evaluation. [29] For children, we assess
whether the impairment(s) causes marked and severe functional
limitations. [30] Genetic test results generally do not provide us with
significant information about impairment severity or functional
capacities.
results in functional limitations that
would prevent him or her from performing past relevant work or other
work at steps 4 and 5 of sequential evaluation. [29] For children, we assess
whether the impairment(s) causes marked and severe functional
limitations. [30] Genetic test results generally do not provide us with
significant information about impairment severity or functional
capacities.

- Can we use genetic test results to establish an MDI (Step 2)? When genetic test results come from an AMS and are not based on DTC
genetic testing, we can use the evidence to establish an MDI if there
are signs and symptoms consistent with the impairment. [31] We can consider
the results of previously-performed genetic testing in establishing an
MDI, if signs and symptoms of an impairment are present. We cannot use
the results of genetic tests, in the absence of any signs or symptoms,
as the sole basis for establishing an MDI, even if the results are
highly- suggestive of the eventual development of an impairment. [32] We
must be able to establish that a person has an MDI at the disability
onset date. Although non-physician geneticists are generally not AMSs, a
physician or other AMS typically reviews or evaluates test results
produced by a non-physician geneticist and incorporates these test
results into an individual's medical record. In such a case, the
evidence can be used to help establish an MDI. Similarly, genetic
counselors are generally not AMSs. Therefore, we cannot establish the
existence of an MDI based solely on a report from a genetic counselor.
However, genetic counselors typically work in a setting where they are
in close collaboration with a physician or other AMS. When a person is
referred for diagnostic testing by a genetic counselor, the results are
often reviewed, evaluated, interpreted, or used by a physician and
incorporated into a medical record. In such a case, this evidence can
help establish an MDI
a genetic counselor.
However, genetic counselors typically work in a setting where they are
in close collaboration with a physician or other AMS. When a person is
referred for diagnostic testing by a genetic counselor, the results are
often reviewed, evaluated, interpreted, or used by a physician and
incorporated into a medical record. In such a case, this evidence can
help establish an MDI. Similar to imaging from an x-ray or MRI, which requires AMS
involvement to establish an MDI, a genetic test result without AMS
involvement cannot establish an MDI. A DTC genetic test result, even if
evaluated, interpreted, or otherwise utilized by an AMS, cannot lead to
the establishment of an MDI because there is no assurance that the test
results belong to a given claimant and no appropriate chain of custody
of the sample is established. Many disorders with a known genetic basis can be, and often are,
established by means other than genetic tests. For example, although
diagnostic genetic tests for cystic fibrosis exist, as do guidelines
surrounding their use, the most common confirmatory test for this
disease is the sweat chloride test, which measures the concentrations of
a certain electrolyte in a person's sweat. [33] It is not a genetic test.
While we consider genetic test results in conjunction with the rest of
the objective medical evidence when they are available, we do not
require a person to undergo such testing to prove they have an MDI or
are disabled.
confirmatory test for this
disease is the sweat chloride test, which measures the concentrations of
a certain electrolyte in a person's sweat. [33] It is not a genetic test.
While we consider genetic test results in conjunction with the rest of
the objective medical evidence when they are available, we do not
require a person to undergo such testing to prove they have an MDI or
are disabled.

- Can we evaluate impairment severity using the results of genetic
tests (Step 2)? To some extent, genetic test results can be helpful in our overall
impairment evaluation, but generally they do not help us determine
whether or not an impairment is severe. For an impairment to be severe,
it must significantly limit an adult's physical or mental ability to do
basic work activities. [34] In the case of a child, for an impairment to be
severe it must be more than a slight abnormality that causes more than
minimal functional limitations. [35] Genetic test results generally do not provide information about the
degree of functional limitation associated with an impairment, but they
can be used to help evaluate for consistency with or supportability of
alleged symptoms and limitations. With the exception of non-mosaic Down
Syndrome, we need evidence other than genetic test results to show a
person's impairment is severe. This evidence comes from other medical
records, a claimant's report of symptoms, and statements from nonmedical
sources. [36]
h an impairment, but they
can be used to help evaluate for consistency with or supportability of
alleged symptoms and limitations. With the exception of non-mosaic Down
Syndrome, we need evidence other than genetic test results to show a
person's impairment is severe. This evidence comes from other medical
records, a claimant's report of symptoms, and statements from nonmedical
sources. [36]

- Can we evaluate medical listings with genetic test results (Step
3)? For several medical listings, we use genetic test results to evaluate
whether a person's impairment meets a medical listing. Four of our
medical listings include, as part of the criteria for an impairment to
meet a listing, the use of appropriate genetic test results. [37] Listings
10.06 and 110.06 for non-mosaic Down syndrome (trisomy 21) use the
results of genetic tests. Karyotyping for Down syndrome is the
“gold standard” for diagnosis. We typically require the
results of karyotype analysis for an impairment to meet 10.06A, 10.06B,
110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test
results for xeroderma pigmentosum to meet listing 8.07A or 108.07A. We may also use genetic test results indicating the presence of a
catastrophic congenital disorder, such as Edward's syndrome (trisomy
18), to find a child's impairment meets listing 110.08. Other medical
listings are for disorders, such as cystic fibrosis [39] and chronic
myelogenous leukemia, with at least one known genetic basis and an
available associated test. [40] Often, additional medical evidence is
required to find a person's impairment meets a relevant listing. [41]
ital disorder, such as Edward's syndrome (trisomy
18), to find a child's impairment meets listing 110.08. Other medical
listings are for disorders, such as cystic fibrosis [39] and chronic
myelogenous leukemia, with at least one known genetic basis and an
available associated test. [40] Often, additional medical evidence is
required to find a person's impairment meets a relevant listing. [41]

- Can we evaluate the degree of limitation and residual functional
capacity (RFC) using genetic test results (Steps 4 and 5)? While genetic tests may help to establish the presence of a disorder
and assist in determining whether an impairment meets or medically
equals a listing, the results alone generally do not provide us with
information about the degree of a person's limitation due to the
impairment. A claimant's RFC reflects the most he or she can do despite
his or her limitations. [42] If an adult's impairment does not meet or
medically equal a listing at step 3 of the sequential evaluation
process, we assess RFC, which applies to both steps 4 and 5. If a
child's impairment does not meet or medically equal a listing, we assess
functional equivalence. Functional equivalence deals with broad areas
of functioning intended to capture all of what a child can or cannot
do. [43] As is the case with RFC, genetic test results alone generally do not
provide us with information about the degree of limitation as it relates
to functional equivalence. To assess a claimant's impairments beyond step 3, we need non-genetic
evidence about the impairment's effect on a person's functioning to
determine the most the person can do despite his or her limitations and
restrictions. [44] Many disorders associated with known gene mutations are
multifactorial in nature. Environmental and other influences that are
not well-understood affect the development of medical signs and symptoms
resulting from the disorder and the degree of limitation a person with
the disorder experiences
oning to
determine the most the person can do despite his or her limitations and
restrictions. [44] Many disorders associated with known gene mutations are
multifactorial in nature. Environmental and other influences that are
not well-understood affect the development of medical signs and symptoms
resulting from the disorder and the degree of limitation a person with
the disorder experiences. Therefore, additional evidence is necessary
to adequately assess a person's RFC and ability to engage in work
activities. However, results of genetic tests can be assessed for consistency
with a person's symptoms and alleged limitations. For example, genetic
test results may lead an AMS to diagnose familial Mediterranean fever.
A common symptom is painful inflammation in various areas of the body,
including joints. [45] If someone complains of significant joint pain
and has genetic test results leading to a diagnosis of familial
Mediterranean fever, we can take into account that the claimant's
reported symptoms are consistent with the genetic test results.

Can we use genetic test results to establish an MDI (Step 2)?

When genetic test results come from an AMS and are not based on DTC
genetic testing, we can use the evidence to establish an MDI if there
are signs and symptoms consistent with the impairment. [31] We can consider
the results of previously-performed genetic testing in establishing an
MDI, if signs and symptoms of an impairment are present. We cannot use
the results of genetic tests, in the absence of any signs or symptoms,
as the sole basis for establishing an MDI, even if the results are
highly- suggestive of the eventual development of an impairment. [32] We
must be able to establish that a person has an MDI at the disability
onset date.
etic testing in establishing an
MDI, if signs and symptoms of an impairment are present. We cannot use
the results of genetic tests, in the absence of any signs or symptoms,
as the sole basis for establishing an MDI, even if the results are
highly- suggestive of the eventual development of an impairment. [32] We
must be able to establish that a person has an MDI at the disability
onset date.

Although non-physician geneticists are generally not AMSs, a
physician or other AMS typically reviews or evaluates test results
produced by a non-physician geneticist and incorporates these test
results into an individual's medical record. In such a case, the
evidence can be used to help establish an MDI. Similarly, genetic
counselors are generally not AMSs. Therefore, we cannot establish the
existence of an MDI based solely on a report from a genetic counselor.
However, genetic counselors typically work in a setting where they are
in close collaboration with a physician or other AMS. When a person is
referred for diagnostic testing by a genetic counselor, the results are
often reviewed, evaluated, interpreted, or used by a physician and
incorporated into a medical record. In such a case, this evidence can
help establish an MDI.

Similar to imaging from an x-ray or MRI, which requires AMS
involvement to establish an MDI, a genetic test result without AMS
involvement cannot establish an MDI. A DTC genetic test result, even if
evaluated, interpreted, or otherwise utilized by an AMS, cannot lead to
the establishment of an MDI because there is no assurance that the test
results belong to a given claimant and no appropriate chain of custody
of the sample is established.
quires AMS
involvement to establish an MDI, a genetic test result without AMS
involvement cannot establish an MDI. A DTC genetic test result, even if
evaluated, interpreted, or otherwise utilized by an AMS, cannot lead to
the establishment of an MDI because there is no assurance that the test
results belong to a given claimant and no appropriate chain of custody
of the sample is established.

Many disorders with a known genetic basis can be, and often are,
established by means other than genetic tests. For example, although
diagnostic genetic tests for cystic fibrosis exist, as do guidelines
surrounding their use, the most common confirmatory test for this
disease is the sweat chloride test, which measures the concentrations of
a certain electrolyte in a person's sweat. [33] It is not a genetic test.
While we consider genetic test results in conjunction with the rest of
the objective medical evidence when they are available, we do not
require a person to undergo such testing to prove they have an MDI or
are disabled.

Can we evaluate impairment severity using the results of genetic
tests (Step 2)?

To some extent, genetic test results can be helpful in our overall
impairment evaluation, but generally they do not help us determine
whether or not an impairment is severe. For an impairment to be severe,
it must significantly limit an adult's physical or mental ability to do
basic work activities. [34] In the case of a child, for an impairment to be
severe it must be more than a slight abnormality that causes more than
minimal functional limitations. [35]
impairment evaluation, but generally they do not help us determine
whether or not an impairment is severe. For an impairment to be severe,
it must significantly limit an adult's physical or mental ability to do
basic work activities. [34] In the case of a child, for an impairment to be
severe it must be more than a slight abnormality that causes more than
minimal functional limitations. [35]

Genetic test results generally do not provide information about the
degree of functional limitation associated with an impairment, but they
can be used to help evaluate for consistency with or supportability of
alleged symptoms and limitations. With the exception of non-mosaic Down
Syndrome, we need evidence other than genetic test results to show a
person's impairment is severe. This evidence comes from other medical
records, a claimant's report of symptoms, and statements from nonmedical
sources. [36]

Can we evaluate medical listings with genetic test results (Step
3)?

For several medical listings, we use genetic test results to evaluate
whether a person's impairment meets a medical listing. Four of our
medical listings include, as part of the criteria for an impairment to
meet a listing, the use of appropriate genetic test results. [37] Listings
10.06 and 110.06 for non-mosaic Down syndrome (trisomy 21) use the
results of genetic tests. Karyotyping for Down syndrome is the
“gold standard” for diagnosis. We typically require the
results of karyotype analysis for an impairment to meet 10.06A, 10.06B,
110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test
results for xeroderma pigmentosum to meet listing 8.07A or 108.07A.
and 110.06 for non-mosaic Down syndrome (trisomy 21) use the
results of genetic tests. Karyotyping for Down syndrome is the
“gold standard” for diagnosis. We typically require the
results of karyotype analysis for an impairment to meet 10.06A, 10.06B,
110.06A, or 110.06B. [38] Additionally, we require diagnostic genetic test
results for xeroderma pigmentosum to meet listing 8.07A or 108.07A.

We may also use genetic test results indicating the presence of a
catastrophic congenital disorder, such as Edward's syndrome (trisomy
18), to find a child's impairment meets listing 110.08. Other medical
listings are for disorders, such as cystic fibrosis [39] and chronic
myelogenous leukemia, with at least one known genetic basis and an
available associated test. [40] Often, additional medical evidence is
required to find a person's impairment meets a relevant listing. [41]

Can we evaluate the degree of limitation and residual functional
capacity (RFC) using genetic test results (Steps 4 and 5)?

While genetic tests may help to establish the presence of a disorder
and assist in determining whether an impairment meets or medically
equals a listing, the results alone generally do not provide us with
information about the degree of a person's limitation due to the
impairment. A claimant's RFC reflects the most he or she can do despite
his or her limitations. [42] If an adult's impairment does not meet or
medically equal a listing at step 3 of the sequential evaluation
process, we assess RFC, which applies to both steps 4 and 5. If a
child's impairment does not meet or medically equal a listing, we assess
functional equivalence. Functional equivalence deals with broad areas
of functioning intended to capture all of what a child can or cannot
do. [43] As is the case with RFC, genetic test results alone generally do not
provide us with information about the degree of limitation as it relates
to functional equivalence.
f a
child's impairment does not meet or medically equal a listing, we assess
functional equivalence. Functional equivalence deals with broad areas
of functioning intended to capture all of what a child can or cannot
do. [43] As is the case with RFC, genetic test results alone generally do not
provide us with information about the degree of limitation as it relates
to functional equivalence.

To assess a claimant's impairments beyond step 3, we need non-genetic
evidence about the impairment's effect on a person's functioning to
determine the most the person can do despite his or her limitations and
restrictions. [44] Many disorders associated with known gene mutations are
multifactorial in nature. Environmental and other influences that are
not well-understood affect the development of medical signs and symptoms
resulting from the disorder and the degree of limitation a person with
the disorder experiences. Therefore, additional evidence is necessary
to adequately assess a person's RFC and ability to engage in work
activities.

However, results of genetic tests can be assessed for consistency
with a person's symptoms and alleged limitations. For example, genetic
test results may lead an AMS to diagnose familial Mediterranean fever.
A common symptom is painful inflammation in various areas of the body,
including joints. [45] If someone complains of significant joint pain
and has genetic test results leading to a diagnosis of familial
Mediterranean fever, we can take into account that the claimant's
reported symptoms are consistent with the genetic test results.

If a person is found disabled,
can we use genetic test results
when setting a diary for continuing disability review (CDR)?
dy,
including joints. [45] If someone complains of significant joint pain
and has genetic test results leading to a diagnosis of familial
Mediterranean fever, we can take into account that the claimant's
reported symptoms are consistent with the genetic test results.

If a person is found disabled,
can we use genetic test results
when setting a diary for continuing disability review (CDR)?

Yes. We consider all impairments and case facts to determine when to
conduct a CDR. We conduct a full evaluation of all evidence, including
genetic test results, when setting diary dates. Due to the diversity of
types of genetic tests and the differing types of information that
genetic test results can provide, the impact of genetic test results on
diary lengths will vary.

What is our policy regarding the
disclosure of the results of genetic tests?

The Privacy Act of 1974 (5 U.S.C. 552a), section 1106 of the Social
Security Act (42 U.S.C. 1306), and our disclosure regulations ( 20 CFR Part
401 ) govern the collection, maintenance, and use of an individual's
information in our systems of records. Although these authorities do
not specifically address requirements for the disclosure of genetic test
results, they apply to the extent we maintain this type of information
in our records.

Under the Privacy Act and our disclosure regulations, we generally
cannot disclose genetic test results without the consent of the subject
of the record. For example, if an individual's MER contains genetic
test results and he or she authorizes us to disclose this specific
information to a third party, we will do so with a valid, written
consent that meets our regulatory requirements.
cords.

Under the Privacy Act and our disclosure regulations, we generally
cannot disclose genetic test results without the consent of the subject
of the record. For example, if an individual's MER contains genetic
test results and he or she authorizes us to disclose this specific
information to a third party, we will do so with a valid, written
consent that meets our regulatory requirements.

In addition, the Privacy Act grants individuals a right of access to
any records we maintain about them in our systems of records.
Therefore, any genetic test results we maintain in an individual's MER
(including records a medical consultative examiner may have generated on
our behalf) are subject to these access requirements, as is the case
with all medical evidence. However, if we determine that direct access
to the medical information is likely to have an adverse effect on the
subject of the record, we will follow certain procedures in providing
access to the information. [46]

EFFECTIVE DATE: This SSR is effective on April 13, 2016.

CROSS REFERENCES: SSR 86-8 ,
Titles II and XVI: The Sequential Evaluation Process; SSR 96-2p , Titles II
and XVI: Giving Controlling Weight to Treating Source Medical Opinions; SSR 96-5p , Titles II
and XVI: Medical Source Opinions on Issues Reserved to the Commissioner; SSR 16-3p ,
Titles II and XVI: Evaluation of Symptoms in Disability Claims; [*] SSR 96-8p , Titles II
and XVI: Assessing Residual Functional Capacity in Initial Claims; SSR 06-3p ,
Titles II and XVI: Considering Opinions and Other Evidence from Sources
Who Are Not “Acceptable Medical Sources” in Disability
Claims; Considering Decisions on Disability by Other Governmental and
Nongovernmental Agencies;
and Program Operations Manual System (POMS)
DI 00115.015, DI 22501.001, DI 22505.001, DI 22505.003, DI 24501.020,
DI 24515.001, DI 24515.061, DI 24515.062, DI 25201.005.
es II and XVI: Considering Opinions and Other Evidence from Sources
Who Are Not “Acceptable Medical Sources” in Disability
Claims; Considering Decisions on Disability by Other Governmental and
Nongovernmental Agencies;
and Program Operations Manual System (POMS)
DI 00115.015, DI 22501.001, DI 22505.001, DI 22505.003, DI 24501.020,
DI 24515.001, DI 24515.061, DI 24515.062, DI 25201.005.

[1] For simplicity, we refer in this SSR only to initial claims for disability
benefits under titles II and XVI of the Social Security Act (Act).
However, the policy interpretations in this SSR also apply to continuing
disability reviews of adults and children under sections 223(f) and 1614(a)(4) of the Act, and to redeterminations of eligibility for
benefits we make in accordance with section 1614(a)(3)(H) of the Act when a child who is receiving title XVI payments based on
disability attains age 18.

[2] For help
with the definitions of the terms and concepts related to genetic
testing in this SSR, see the National Human Genome Research Institute
(NHGRI) Talking Glossary of Genetic Terms, available at http://www.genome.gov/glossary/index.cfm .

[3] Clinicians may perform gene expression profiling for certain types of
malignant tumors to gather information for cancer treatment. We do not
consider such tests in this SSR.

[4] See the Genetics Home Reference page for hemochromatosis available at http://ghr.nlm.nih.gov/condition/hemochromatosis .

[5] See the
National Cancer Institute, at the National Institutes of Health's,
discussion of BRCA1 and BRCA2 , available at http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional/page2 .

[6] We do
not make a determination of disability for fetuses. We can, however,
consider the results of certain prenatal genetic tests as part of the
MER in accordance with our policy once the child is born and a
disability claim has been filed on his or her behalf.
n of BRCA1 and BRCA2 , available at http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional/page2 .

[6] We do
not make a determination of disability for fetuses. We can, however,
consider the results of certain prenatal genetic tests as part of the
MER in accordance with our policy once the child is born and a
disability claim has been filed on his or her behalf.

[7] Current
statistics on genetic variants and corresponding conditions can be found
at the Online Mendelian Inheritance in Man database on the
“Statistics” page, available at http://www.ncbi.nlm.nih.gov/clinvar/submitters/ or http://www.omim.org/statistics/entry .

[8] See the
NCBI Genetic Testing Registry, available at http://www.ncbi.nlm.nih.gov/gtr/all/tests/?term=all%5bsb (last
visited August 2015). See also, the American Medical Association (AMA)
page regarding genetic testing, available at http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/related-policy-topics/genetic-testing.page ? See
also, the Centers for Disease Control and Prevention (CDC) page
regarding genetic testing, available at http://www.cdc.gov/genomics/gtesting/ .

[9] Under
listings 10.06A and 110.06A, a laboratory report of karyotype analysis
not signed by a physician is also sufficient if it is accompanied by a
statement of a physician that the person has Down syndrome.

[10] These
listings are for xeroderma pigmentosum (8.07A and 108.07A), 20 CFR part 404,
subpart P, appendix 1 .

[11] 20 CFR
404.1512(b)(1) , 404.1513(b)(3) , 404.1520(a)(3) , 404.1528(c) , 416.912(b)(1) , 416.913(b)(3) , 416.920(a)(3) , 416.928(c) .

[12] 20 CFR
404.1512(d) , 404.1519m , 416.912(d) , and 416.919m .

[13] 20 CFR
404.1512(b) , 404.1513(d) , 404.1527 , 416.912(b) , 416.913(d) , and 416.927 . SSR 06-03p.

[14] 20 CFR
404.1512(b) , 404.1520(a)(3) , 416.912(b) , 416.920(a)(3) , 416.924(a) , and 416.924a(a)(1)(i) .

[15] 20 CFR 404.1520b and 416.920b

[16] 20 CFR 404.1505(a) and 416.905(a) .
)(3) , 416.920(a)(3) , 416.928(c) .

[12] 20 CFR
404.1512(d) , 404.1519m , 416.912(d) , and 416.919m .

[13] 20 CFR
404.1512(b) , 404.1513(d) , 404.1527 , 416.912(b) , 416.913(d) , and 416.927 . SSR 06-03p.

[14] 20 CFR
404.1512(b) , 404.1520(a)(3) , 416.912(b) , 416.920(a)(3) , 416.924(a) , and 416.924a(a)(1)(i) .

[15] 20 CFR 404.1520b and 416.920b

[16] 20 CFR 404.1505(a) and 416.905(a) .

[17] 20 CFR 404.1508 and 416.908 .

[18] Listings 8.07, 10.06A, 10.06B, 108.07, 110.06A, and 110.06B, 20 CFR part 404,
subpart P, appendix 1 , require genetic testing results in order for
these impairments (genetic photosensitivity disorders and non-mosaic
Down syndrome) to meet the listing.

[19] 20 CFR 404.1513(a) , 404.1513(d) , 416.913(a) , and 416.913(d)

[20] See the National Society of Genetic Counselors (NSGC) page regarding genetic
counselor licensure, available at http://nsgc.org/p/cm/ld/fid=18 .

[21] 20 CFR
404.1513(d) and 416.913(d) .

[22] See the Genetics Home Reference page, a service of the U.S. National Library
of Medicine, detailing what direct-to-consumer genetic testing is,
available at http://ghr.nlm.nih.gov/handbook/testing/directtoconsumer . See
also, the American College of Preventative Medicine's Genetic Testing
Clinical Reference for Clinicians and Genetic Testing Time tool pages,
illustrating the growth of genetic testing, available at http://www.acpm.org/?GeneticTestgClinRef .

[23] See Yale
Journal of Biology and Medicine, Direct-to-Consumer Genetic Testing: A
Comprehensive View. (Yale J Biol Med. Sep 2013; 86(3): 359-365). See
also, the American Society of Human Genetics statement on
direct-to-consumer genetic testing in the United States. (Am. J. Hum.
Genet. 2007; 81: 635-637).

[24] 20 CFR 404.1508 and 416.908 .

[25] 20 CFR 404.1520b and 416.920b .

[26] Step 1 of the sequential evaluation process considers work activity and whether
a claimant is engaged in substantial gainful activity. Genetic testing
or genetic test results do not impact this step.
netics statement on
direct-to-consumer genetic testing in the United States. (Am. J. Hum.
Genet. 2007; 81: 635-637).

[24] 20 CFR 404.1508 and 416.908 .

[25] 20 CFR 404.1520b and 416.920b .

[26] Step 1 of the sequential evaluation process considers work activity and whether
a claimant is engaged in substantial gainful activity. Genetic testing
or genetic test results do not impact this step.

[27] For
children, we will consider whether you have more than a slight
abnormality or combination of slight abnormalities that cause more than
minimal functional limitations. See 20 CFR 404.1520(c) , 416.920(c) , and 416.924(c) .

[28] See FN 18 .

[29] 20 CFR 404.1520(f) , 404.1520(g) , 416.920(f) , and 416.920(g) .

[30] 20 CFR 416.906 and 416.926a .

[31] Predictive, as opposed to diagnostic, test results from an AMS do not
constitute laboratory results that can establish an MDI.

[32] For
example, see FN5 regarding the predictive nature of genetic tests for BRCA1 and BRCA2 . The meeting of listings 10.06 or 110.06,
based on a karyotype report signed by a physician, would be an
exception.

[33] See http://www.nlm.nih.gov/medlineplus/ency/article/003630.htm .

[34] 20 CFR 404.1520(c) and 416.920(c) .

[35] 20 CFR
416.924(c) .

[36] In cases
of a catastrophic congenital disorder, as detailed in listing 110.08, 20 CFR part 404,
subpart P, appendix 1 , or other extreme cases, genetic
test results alone may show a person's impairment is severe.

[37] These
listings include those for xeroderma pigmentosum (8.07A and 108.07A) and
non-mosaic Down syndrome (10.06A and 110.06A), 20 CFR part 404,
subpart P, appendix 1 .
[36] In cases
of a catastrophic congenital disorder, as detailed in listing 110.08, 20 CFR part 404,
subpart P, appendix 1 , or other extreme cases, genetic
test results alone may show a person's impairment is severe.

[37] These
listings include those for xeroderma pigmentosum (8.07A and 108.07A) and
non-mosaic Down syndrome (10.06A and 110.06A), 20 CFR part 404,
subpart P, appendix 1 .

[38] Listings 10.06 and 110.06, 20 CFR part 404,
subpart P, appendix 1 , require that a
claimant's non-mosaic Down syndrome be documented by: A. a laboratory
report of karyotype analysis signed by a physician, or both a laboratory
report of karyotype analysis not signed by a physician and a statement
by a physician that you have Down syndrome (see 10.00C1); B. a
physician's report stating that you have chromosome 21 trisomy or
chromosome 21 translocation consistent with prior karyotype analysis
with the distinctive facial or other physical features of Down syndrome
(see 10.00C2a); or C. a physician's report stating that you have Down
syndrome with the distinctive facial or other physical features and
evidence demonstrating that you function at a level consistent with
non-mosaic Down syndrome (see 10.00C2b).

[39] Listings 3.04 and 103.04, 20 CFR part 404,
subpart P, appendix 1 .

[40] Listings 13.06B and 113.06B, 20 CFR part 404,
subpart P, appendix 1 .

[41] 20 CFR part 404,
subpart P, appendix 1 . For example, Marfan syndrome (listings
4.00H and 104.00F) and genetic photosensitivity disorders other than
xeroderma pigmentosum (listing 8.07 and 108.07).

[42] 20 CFR 404.1545 and 416.945 .

[43] 20 CFR 416.906 and 416.926a .

[44] 20 CFR 404.1545(a) , 416.945(a) , and SSR 96-8p , Titles II and
XVI: Assessing Residual Functional Capacity in Initial Claims (1996),
61 FR 34474, available at http://www.socialsecurity.gov/OP_Home/rulings/di/01/SSR96-08-di-01.html .
tosensitivity disorders other than
xeroderma pigmentosum (listing 8.07 and 108.07).

[42] 20 CFR 404.1545 and 416.945 .

[43] 20 CFR 416.906 and 416.926a .

[44] 20 CFR 404.1545(a) , 416.945(a) , and SSR 96-8p , Titles II and
XVI: Assessing Residual Functional Capacity in Initial Claims (1996),
61 FR 34474, available at http://www.socialsecurity.gov/OP_Home/rulings/di/01/SSR96-08-di-01.html .

[45] See http://ghr.nlm.nih.gov/condition/familial-mediterranean-fever . [46] 20 CFR 401.55 . [*] Federal Register Vol. 81,
No. 77, page 23543 removed reference "SSR 96-7p, Titles II and XVI: Evaluation of Symptoms
in Disability Claims: Assessing the Credibility of an Individual's
Statements;" and replaced it with "SSR 16-3p, Titles II and XVI:
Evaluation of Symptoms in Disability Claims."

[46] 20 CFR 401.55 .

[*] Federal Register Vol. 81,
No. 77, page 23543 removed reference "SSR 96-7p, Titles II and XVI: Evaluation of Symptoms
in Disability Claims: Assessing the Credibility of an Individual's
Statements;" and replaced it with "SSR 16-3p, Titles II and XVI:
Evaluation of Symptoms in Disability Claims."

Back
to Table of Contents

## Nearby sections

- [SSR 00-1c SSR 00-1c: Sections 222(c) and 223(a), (d)(2)(a), and (e)(1) of the Social Security Act (42 U.S.C. 422(c) and 423(a), (d)(2)(A), and (e)(1)) Disability Insurance Benefits—Claims Filed Under Both the Social Security Act and the Americans with Disabilities Act](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_00_1c.md)
- [SSR 00-3p SSR 00-3p: Superseded](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_00_3p.md)
- [SSR 02-1p SSR 02-1p: Rescinded](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_02_1p.md)
- [SSR 02-2p SSR 02-2p: Rescinded](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_02_2p.md)
- [SSR 03-01p SSR 03-01p: SSR 03-1p: Titles II and XVI: Development and Evaluation of Disability Claims Involving Postpolio Sequelae](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_03_01p.md)
- [SSR 03-02p SSR 03-02p: SSR 03-2p: Titles II and XVI: Evaluating Cases Involving Reflex Sympathetic Dystrophy Syndrome/Complex Regional Pain Syndrome](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_03_02p.md)
- [SSR 03-03p SSR 03-03p: SSR 03-3p: Policy Interpretation Ruling - Titles II and XVI: Evaluation of Disability and Blindness in Initial Claims for Individuals Aged 65 or Older](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_03_03p.md)
- [SSR 06-01p SSR 06-01p: Titles II and XVI: Evaluating Cases Involving Tremolite Asbestos-Related Impairments](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_06_01p.md)
- [SSR 06-03p SSR 06-03p: Rescinded](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_06_03p.md)
- [SSR 07-01p SSR 07-01p: Titles II and XVI: Evaluating Visual Field Loss Using Automated Static Threshold Perimetry](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_07_01p.md)
- [SSR 11-1p SSR 11-1p: Titles II and XVI: Procedures for Handling Requests to File Subsequent Applications for Disability Benefits](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_11_1p.md)
- [SSR 11-2p SSR 11-2p: Titles II and XVI: Documenting and Evaluating Disability in Young Adults](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_11_2p.md)
- [SSR 12-2p SSR 12-2p: Titles II and XVI: Evaluation of Fibromyalgia](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_12_2p.md)
- [SSR 13-2p SSR 13-2p: TITLES II AND XVI: EVALUATING CASES INVOLVING DRUG ADDICTION AND ALCOHOLISM (DAA)](https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_13_2p.md)

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/SSA_SSR_DI_SSR_16_4p. Check the current official text before relying on it. Not legal advice.
